Search results for: Value-Based Pricing
Filter search results
Surgical Research and Development in the NHS – Promotion, Management and Evaluation
1 July 2000
Based on papers delivered at the OHE Conference, London, 25 November 1997. Based on papers delivered at the OHE Conference, London, 25 November 1997. The UK National Health Service (NHS)…
What Determines the Shape of an EQ-5D Index Distribution?
1 August 2014
…of EQ-5D distributions, particularly the origins of the ‘two groups’ distribution. The authors compare distributions of EQ-5D index values with distributions based on data that have not been weighted and…
Comparing the EQ-5D-3L and EQ-5D-5L in a Cohort of Cancer Patients: A Research Collaboration between OHE, Curtin University and King’s College London
15 August 2017
…large cohort of cancer patients. The existence of important dissimilarities between EQ-5D-3L and the newer EQ-5D-5L, in terms of both the health profiles and preference-based values, is a key topic…
Opportunity Cost in Health Care: a Favourite Research Topic for OHE
23 November 2021
…will be allocated fairly and efficiently. Defining ‘opportunity cost’ is simple enough; it is represented by the value of the choices we don’t make. For instance, the opportunity cost of…
Mata Charokopou – 2022 Prize Finalist
18 January 2023
Mata Charokopou, PharmD, MSc, Senior Director – Head of Global Payer Strategy & Health Economics in UCB. She is responsible for the development of evidence generation strategies, patient value strategy…
Patricia Cubi-Molla
4 September 2015
Dr Patricia Cubi-Molla, PhD, Senior Principal Economist at the Office of Health Economics (OHE), specialising in value assessment and healthcare decision-making. She leads OHE’s research theme on Value, Affordability, and Decision-Making and…
OHE at the 2019 International Health Economics Association (iHEA) World Congress
5 July 2019
…issues concerning the quality of care, variation of hospital readmission, waiting time for hospital admission etc. Quantifying the Life-Cycle Value of Innovative Medicines: The Case of Risperidone and Second-Generation Antipsychotics…
Novel devices: optimising drug delivery in multiple myeloma
9 December 2025
…integral to multiple myeloma treatment. Wider adoption of On-Body Injectors can help overcome formulation and delivery challenges, unlocking the full value of biologics and other anti-cancer medicines. This contract research…
OHE Awarded DH Grant for EQ-5D Research
13 April 2010
…programme to assess the quality of care provided in different settings. The research for this grant consists of three sets of studies. The first will map the 5L to 3L values…